|1.||Qin, Ling: 3 articles (08/2015 - 02/2009)|
|2.||Meng, Kun: 2 articles (10/2015 - 01/2011)|
|3.||Lee, Kwong-Man: 2 articles (08/2015 - 02/2009)|
|4.||Xie, Xin-Hui: 2 articles (08/2015 - 02/2009)|
|5.||Zhang, Ge: 2 articles (08/2015 - 02/2009)|
|6.||Griffith, James F: 2 articles (08/2015 - 02/2009)|
|7.||Pan, Xiaohua: 2 articles (08/2015 - 08/2015)|
|8.||Wang, Xin-Luan: 2 articles (08/2015 - 02/2009)|
|9.||Yong, Eu-Leong: 2 articles (07/2015 - 05/2012)|
|10.||Xu, H Eric: 2 articles (07/2015 - 05/2012)|
05/01/2013 - "In vivo study, it was also observed that icaritin prolonged survival of peritonitis mice, and inhibited massive leukocyte influx into the peritoneal cavity. "
05/01/2013 - "Icaritin exhibits anti-inflammatory effects in the mouse peritoneal macrophages and peritonitis model."
05/01/2013 - "The purpose of this study was to investigate the protective effects of icaritin on inflammation in lipopolysaccharide (LPS) stimulated mouse peritoneal macrophages in vitro and zymosan induced peritonitis model in vivo. "
|2.||Liver Cirrhosis (Hepatic Cirrhosis)
09/01/2011 - "Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats."
09/01/2011 - "The purpose of this study is to investigate the effects and mechanisms of icaritin-induced cell death in activated hepatic stellate cells (HSCs) and ameliorating the development of liver fibrosis in rats. "
09/01/2011 - "Icaritin can induce cell death in activated HSCs through mitochondria-mediated apoptosis, ameliorate the progression of hepatic fibrosis in rats, and could be a promising drug for treating liver fibrosis."
|4.||Urinary Bladder Neoplasms (Bladder Cancer)
01/01/2016 - "These findings suggest that icaritin may prove to be a novel potent therapeutic agent for the treatment of bladder cancer. "
01/01/2016 - "In the present study, we investigated the effect and mechanisms of icaritin, a flavonol glycoside derived from genus Epimedium, against human bladder cancer cells. "
01/01/2016 - "It was found that despite the low cytotoxicity in normal human HEK293 cells, icaritin significantly inhibited the proliferation and colony formation of BT5637 and T24 bladder cancer cells time- and dose-dependently compared to the DMSO vehicle control. "
01/01/2016 - "Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy."
|2.||polylactic acid-polyglycolic acid copolymer (PLGA)
|8.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|9.||Small Interfering RNA (siRNA)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)